Showing results (391-400 of 430) with videos related to

Sort By:
Pageof 43
New Biotechnology|April 13, 2023
An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemicsShayan G Borhani, Max Z Levine, Lauren H Krumpe, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemicsShayan G Borhani, Max Z Levine, Lauren H Krumpe, et al.
Plos One|September 8, 2023
Examination of ELISA against PCR for assessing treatment efficacy against Cryptosporidium in a clinical trial contextJames T Nyirenda, Marc Y R Henrion, Vita Nyasulu, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trialMichele Tameris, Helen Mearns, Adam Penn-Nicholson, et al.
BMC Genomics|December 21, 2019
RNA-seq, de novo transcriptome assembly and flavonoid gene analysis in 13 wild and cultivated berry fruit species with high content of phenolicsVera Thole, Jean-Etienne Bassard, Ricardo Ramírez-González, et al.
Cancers|February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma CellsMarius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
International Journal of Cancer|July 16, 2019
Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease modelTheresa M Thole, Joern Toedling, Annika Sprüssel, et al.
Klinische Padiatrie|May 9, 2025
GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Journal of Personalized Medicine|August 27, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel SequencingAnnabell Szymansky, Louisa-Marie Kruetzfeldt, Lukas C Heukamp, et al.
Cancer Research Communications|January 6, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with NeuroblastomaJan F Hollander, Annabell Szymansky, Jasmin Wünschel, et al.
Pageof 43